glp-1 conference Millions could benefit from medications. So why can't they get them? Experts at #MIGlobal2026 point to three major barriers: • High costs • Insurance coverage gaps • Care models that don't GLP-1 Agonists: The Good, The

All medical content on this blog is created using reputable, evidence-based sources and is regularly reviewed for accuracy and relevance

The regulatory outcome could affect the ongoing availability of Omzo's compounded GLP-1 offerings

Does the type of GLP-1 (oral vs injectable) change the early dosing rules

Month 1: adjustment period Expect minimal weight loss during the first month

This reflects a key limitation: GLP-1 medications can reduce appetite and support weight loss, but they do not by themselves establish a long-term metabolic framework for maintaining that loss

Compounded medications are only indicated for patients when a prescribing practitioner determines that the compounded preparation produces a significant difference for their patient compared to the FDA-approved product